MIDN and hepatocellular carcinoma: Another study found that overexpressed midnolin facilitated the progression of hepatocellular carcinoma (HCC), also discovering that the suppression of midnolin disrupted retinoic acid/lipid metabolism in HCC cells and restrained tumor growth [11].